Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p53 as a prognostic factor for stage III serous adenocarcinoma of the ovary.

Anticancer research - 1 Jan 2000

Daponte A, Guidozi F, Tiltman A J, Marineanu A, Taylor L

Abstract excerpt

Expression of mutant p53 in 19 patients with stage III moderately differentiated serous cystadenocarcinoma of the ovary, who all had optimal primary cytoreductive surgery and six cycles of cisplatin and cyclophosphamide was analyzed to determine its prognostic significance. All patients were followed up for a minimum of 48 months. Immunohistochemical analysis for mutant p53 was by means of monoclonal antibody DO7...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Combined Modality Therapy
Share to Antineoplastic Combined Chemotherapy Protocols

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cisplatin

Share to Cyclophosphamide

Share to Genes, p53

Share to Neoplasm Staging

Share to Ovarian Neoplasms

Share to Proportional Hazards Models

Source

Identifiers

PMID: 10472362

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p53 as a prognostic factor for stage III serous adenocarcinoma of the ovary.PMID 10472362Read ↗

Mutant p53 product in patients with stage III cervical cancer.Semantic proximity Read ↗

Prognostic value of overexpression of p53 in human ovarian carcinoma patients receiving cisplatin.Semantic proximity Read ↗

[P53-status in primary ovarian carcinomas, ovarian metastases of neoplasms in other sites and benign ovarian tumors: predictive value in comparison to histopathological parameters].Semantic proximity Read ↗

The prognostic significance of p53 tumor suppressor gene alterations in ovarian carcinoma.Semantic proximity Read ↗

p53 overexpression as a prognostic indicator in endometrial carcinoma.Semantic proximity Read ↗

p53 expression in epithelial ovarian neoplasms: relationship to clinical and pathological parameters, Ki-67 expression and flow cytometry.Semantic proximity Read ↗

p53 tumor suppressor gene protein expression in cervical cancer: relationship to prognosis.Semantic proximity Read ↗

Mutant p53 in patients with invasive cervical cancer stages IB to IIB.Semantic proximity Read ↗

Relationship between p53 expression and other prognostic factors in human breast carcinoma. An immunohistochemical study.Semantic proximity Read ↗

Immunohistochemical detection of mutant p53-suppressor gene product in patients with breast cancer: influence on metastasis-free survival.Semantic proximity Read ↗

Adenovirus-based p53 gene therapy in ovarian cancer.Semantic proximity Read ↗

Usefulness of immunohistochemical staining for p53 in the prognosis of breast carcinomas: correlations with established prognosis parameters and with the proliferation marker, MIB-1.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.